Abstract
Due to recent advances in medical technologies, cancer has become more curable and chronic, and post-treatment quality of life, including male fertility, has become an important issue. Cancer itself can affect spermatogenesis through complex interactions, and cancer treatment such as surgery, radiotherapy and chemotherapy, all have certain detrimental effects on spermatogenesis. Currently, sperm cryopreservation before cancer treatment is the mainstay of fertility preservation, and is recommended by numerous guidelines. Although fertility preservation should be discussed with all cancer patients before treatment, it still remains underused. Postpubertal patients who are unable to bank sperm may undergo testicular sperm extraction before treatment. For prepubertal boys, there is no clinically established guideline for fertility preservation. Investigations such as spermatogonial stem cell culture are ongoing, and may lead to clinical options for fertility preservation in the future.
Similar content being viewed by others
References
Centers for Disease Control and Prevention (CDC). Cancer survivors—United States, 2007. MMWR Morb Mortal Wkly Rep. 2011;60(9):269–72.
Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol. 2002;20:1880–9.
Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer. 2005;104:521–4.
Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–8.
Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.
Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.
Naysmith TE, Blake DA, Harvey VJ, Johnson NP. Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod. 1998;13:3250–5.
Wong WY, Thomas CM, Merkus JM, Zielhuis GA, Steegers-Theunissen RP. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril. 2000;73:435–42.
Costabile RA, Spevak M. Cancer and male factor infertility. Oncology (Williston Park). 1998;12:557–70.
van Casteren NJ, Boellaard WP, Romijn JC, Dohle GR. Gonadal dysfunction in male cancer patients before cytotoxic treatment. Int J Androl. 2010;33(1):73–9.
Petersen PM, Skakkebaek NE, Vistisen K, Rorth M, Giwercman A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol. 1999;17:941–7.
Jacobsen KD, Theodorsen L, Fossa SD. Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy. J Urol. 2001;165:93–6.
Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod. 2001;16:972–8.
Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Int Med. 2009;169:351–6.
Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, Moller H. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ. 2000;321:789–92.
Mukherjee S, Ridgeway AD, Lamb DJ. DNA mismatch repair and infertility. Curr Opin Urol. 2010;20:525–32.
Gonsalves J, Sun F, Schlegel PN, Turek PJ, Hopps CV, Greene C, Martin RH, Pera RA. Defective recombination in infertile men. Hum Mol Genet. 2004;13:2875–83.
Maduro MR, Casella R, Kim E, Lévy N, Niederberger C, Lipshultz LI, Lamb DJ. Microsatellite instability and defects in mismatch repair proteins: a new aetiology for Sertoli cell-only syndrome. Mol Hum Reprod. 2003;9:61–8.
Matzuk MM, Lamb DJ. The biology of infertility: research advances and clinical challenges. Nat Med. 2008;14:1197–213.
Eisenberg ML, Betts P, Herder D, Lamb DJ, Lipshultz LI. Increased risk of cancer among azoospermic men. Fertil Steril. 2013;100(3):681–5.
Petersen PM, Skakkebaek NE, Vistisen K, Rørth M, Giwercman A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol. 1999;17:941–7.
Liguori G, Trombetta C, Bucci S, Benvenuto S, Amodeo A, Ocello G, Belgrano E. Semen quality before and after orchiectomy in men with testicular cancer. Arch Ital Urol Androl. 2008;80(3):99–102.
Herr HW, Bar-Chama N, O’Sullivan M, Sogani PC. Paternity in men with stage I testis tumors on surveillance. J Clin Oncol. 1998;16:733–4.
Donohue JP, Thornhill JA, Foster RS, Rowland RG, Bihrle R. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965–1989. Br J Urol. 1993;71:326–35.
Pettus JA, Carver BS, Masterson T, Stasi J, Sheinfeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology. 2009;73:328–32.
Coogan CL, Hejase MJ, Wahle GR, Foster RS, Rowland RG, Bihrle R, Donohue JP. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer. J Urol. 1996;156:1656–8.
Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fosså SD. Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer. 1999;80:249–55.
Steiner H, Peschel R, Bartsch G. Retroperitoneal lymph node dissection after chemotherapy for germ cell tumours: is a full bilateral template always necessary? BJU Int. 2008;102:310–4.
Nonomura N, Nishimura K, Takaha N, Inoue H, Nomoto T, Mizutani Y, Nakao M, Okuyama A, Miki T. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy. Int J Urol. 2002;9:539–44.
Gilja I, Parazajder J, Cvitkovic P, Kovacic M. Retrograde ejaculation and loss of emission: possibilities of conservative treatment. Eur Urol. 1994;25:256–8.
Narayan P, Lange P, Fraley E. Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J Urol. 1982;127:685–8.
Reynolds JC, McCall A, Kim E, Lipshultz L. Bladder neck collagen injection restores antegrade ejaculation after bladder neck surgery. J Urol. 1998;159:1303.
Hsiao W, Deveci S, Mulhall JP. Outcomes of the management of post-chemotherapy retroperitoneal lymph node dissection-associated anejaculation. BJU Int. 2012;110(8):1196–200.
Jonas D, Linzbach P, Weber W. The use of Midodrin in the treatment of ejaculation disorders following retroperitoneal lymphadenectomy. Eur Urol. 1979;5:184–7.
Stewart BH, Bergant J. Correction of retrograde ejaculation by sympathomimetic medication: a preliminary report. Fertil Steril. 1974;25:1073–4.
Stockamp K, Schreiter F, Altwein J. Alpha-adrenergic drugs in retrograde ejaculation. Fertil Steril. 1974;25:817–20.
Okada H, Fujioka H, Tatsumi N, Kanzaki M, Inaba Y, Fujisawa M, Gohji K, Arakawa S, Kamidono S. Treatment of patients with retrograde ejaculation in the era of modern assisted reproduction technology. J Urol. 1998;159:848–50.
Yuanhui X. Treatment of functional retrograde ejaculation with acupuncture and TCM herbal drugs. J Tradit Chin Med. 2002;22:286–7.
Virupannavar C, Tomera F. An unusual case of retrograde ejaculation and a brief review of management. Fertil Steril. 1982;37:275–6.
Jefferys A, Siassakos D, Wardle P. The management of retrograde ejaculation: a systematic review and update. Fertil Steril. 2012;97(2):306–12.
Hutling C, Rosenlund B, Tomblom M. Transrectal electroejaculation in combination with in-vitro fertilization: an effective treatment of anejaculatory infertility after testicular cancer. Hum Reprod. 1995;10:847–50.
Rosenlund B, Sjoblom P, Tornblom M, Hutling C, Hillsenjo T. In-vitro fertilization and intracytoplasmic sperm injection in the treatment of infertility after testicular cancer. Hum Reprod. 1998;13:414–8.
Trost LW, Brannigan RE. Oncofertility and the male cancer patient. Curr Treat Options Oncol. 2012;13(2):146–60.
Centola GM, Keller JW, Henzler M, Rubin P. Effect of low-dose testicular irradiation on sperm count and fertility in patients with testicular seminoma. J Androl. 1994;15:608–13.
Ash P. The influence of radiation on fertility in man. Br J Radiol. 1980;53:271–8.
Pryzant RM, Meistrich ML, Wilson G, Brown B, McLaughlin P. Long-term reduction in sperm count after chemotherapy with and without radiation for non-Hodgkin’s lymphomas. J Clin Oncol. 1993;11:239–47.
Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin N Am. 1998;27:927–43.
Shalet SM. Effect of irradiation treatment on gonadal function in men treated for germ cell cancer. Eur Urol. 1993;23:148–51.
Hart R. Preservation of fertility in adults and children diagnosed with cancer. BMJ. 2008;337:a2045.
Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59:665–78.
Shalet SM, Tsatsoulis A, Whitehead E, Read G. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol. 1989;120:161–5.
Brauner R, Czernichow P, Cramer P, Schaison G, Rappaport R. Leydig-cell function in children after direct testicular irradiation for acute lymphoblastic leukemia. N Engl J Med. 1983;309:25–8.
Sklar CA, Robison LL, Nesbit ME, Sather HN, Meadows AT, Ortega JA, Kim TH, Hammond GD. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol. 1990;8:1981–7.
Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med. 1989;70:145–60.
Giwercman A, Petersen PM. Cancer and male infertility. Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14:453–71.
Stahl PJ, Stember DS, Hsiao W, Schlegel PN. Indications and strategies for fertility preservation in men. Clin Obstet Gynecol. 2010;53:815–27.
Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–7.
Tal R, Botchan A, Hauser R, Yogev L, Paz G, Yavetz H. Follow-up of sperm concentration and motility in patients with lymphoma. Hum Reprod. 2000;15:1985–8.
Pryzant RM, Meistrich ML, Wilson G, Brown B, McLaughlin P. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin’s lymphomas. J Clin Oncol. 1993;11:239–47 (Erratum in: J Clin Oncol. 1993;11:1007).
Drasga RE, Einhorn LH, Williams SD, Patel DN, Stevens EE. Fertility after chemotherapy for testicular cancer. J Clin Oncol. 1983;1:179–83.
Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997;15:239–45.
Petersen PM, Hansen SW, Giwercman A, Rørth M, Skakkebaek NE. Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol. 1994;5:355–8.
Ishikawa T, Kamidono S, Fujisawa M. Fertility after high-dose chemotherapy for testicular cancer. Urology. 2004;63:137–40.
Hourvitz A, Goldschlag DE, Davis OK, Gosden LV, Palermo GD, Rosenwaks Z. Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates. Fertil Steril. 2008;90:557–63.
Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Gustafsson H, Löfvander Thapper K, Jepson K, Spanò M, Wiebe T, Lundberg Giwercman Y, Giwercman A. Sperm DNA integrity in men treated for childhood cancer. Clin Cancer Res. 2010;16:3843–50.
Salonia A, Gallina A, Matloob R, Rocchini L, Saccà A, Abdollah F, Colombo R, Suardi N, Briganti A, Guazzoni G, Rigatti P, Montorsi F. Is sperm banking of interest to patients with nongerm cell urological cancer before potentially fertility-damaging treatments? J Urol. 2009;182:1101–7.
Schmidt KT, Andersen CY. Recommendations for fertility preservation in patients with lymphomas. J Assist Reprod Genet. 2012;29:473–7.
Chang HC, Chen SC, Chen J, Hsieh JT. Initial 10-year experience of sperm cryopreservation services for cancer patients. J Formos Med Assoc. 2006;105:1022–6.
Yee S, Fuller-Thomson E, Dwyer C, Greenblatt E, Shapiro H. “Just what the doctor ordered”: factors associated with oncology patients’ decision to bank sperm. Can Urol Assoc J. 2012;6:E174–8.
Ping P, Zhu WB, Zhang XZ, Yao KS, Xu P, Huang YR, Li Z. Sperm banking for male reproductive preservation: a 6-year retrospective multi-centre study in China. Asian J Androl. 2010;12:356–62.
Navarro Medina P, Barroso Deyne E, Castillo Suárez M, Blanco Diez A, Lozano M, Artiles Hernández JL, Chesa Ponce N. An analysis of our experience in cryopreservation of semen from cancer patients. Actas Urol Esp. 2010;4:101–5.
Chung K, Irani J, Knee G, Efymow B, Blasco L, Patrizio P. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol. 2004;113:S7–11.
Lass A, Akagbosu F, Abusheikha N, Hassouneh M, Blayney M, Avery S, Brinsden P. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Hum Reprod. 1998;13:3256–61.
Nahata L, Cohen LE, Yu RN. Barriers to fertility preservation in male adolescents with cancer: it’s time for a multidisciplinary approach that includes urologists. Urology. 2012;79:1206–9.
Klosky JL, Randolph ME, Navid F, Gamble HL, Spunt SL, Metzger ML, Daw N, Morris EB, Hudson MM. Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol. 2009;26:252–60.
Quinn GP, Vadaparampil ST, Lee JH, Jacobsen PB, Bepler G, Lancaster J, Keefe DL, Albrecht TL. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952–7.
Hartmann JT, Albrecht C, Schmoll HJ, Kuczyk MA, Kollmannsberger C, Bokemeyer C. Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer. 1999;80:801–7.
Rieker PP, Fitzgerald EM, Kalish LA, Richie JP, Lederman GS, Edbril SD, Garnick MB. Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer. 1989;64:2399–407.
Rieker PP, Fitzgerald EM, Kalish LA. Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol. 1990;8:347–55.
Bizet P, Saias-Magnan J, Jouve E, Grillo JM, Karsenty G, Metzler-Guillemain C, Perrin J. Sperm cryopreservation before cancer treatment: a 15-year monocentric experience. Reprod Biomed Online. 2012;24:321–30.
Nishiyama H, Soda T, Ichioka K, Okubo K, Ogawa O. Questionnaire survey in Japan for sperm cryopreservation before chemotherapy. Hinyokika Kiyo. 2008;54:593–8.
Watanabe C, Takahashi M, Kai I. Hematologist practices and attitude toward chemotherapy-related infertility. Gan To Kagaku Ryoho. 2007;34:891–6.
Crha I, Ventruba P, Zakova J, Huser M, Kubesova B, Hudecek R, Jarkovsky J. Survival and infertility treatment in male cancer patients after sperm banking. Fertil Steril. 2009;91:2344–8.
Agarwal A, Ranganathan P, Kattal N, Pasqualotto F, Hallak J, Khayal S, Mascha E. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril. 2004;81:342–8.
Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fosså SD. Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it? Eur Urol. 2005;48:779–85.
van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008;90:2245–50.
Suzuki K, Matuzaki J, Hattori Y, Saito K, Noguchi K, Yumura Y, Sato K, Iwasaki A, Kubota Y. Semen cryopreservation for patients with malignant or non-malignant disease: our 14-year experience. Hinyokika Kiyo. 2007;53:539–44.
Soda T, Okubo K, Ichioka K, Okuno H, Kohama N, Nakayama T, Hatayama H, Nishiyama H, Ogawa O. Sperm cryopreservation for cancer patients: 5-year experience in a private hospital in Japan. Hinyokika Kiyo. 2009;55:9–13.
Taniguchi H, Hiura Y, Chizaki R, Kawakita S, Kawa G, Kinoshita H, Murota T, Matsuda T, Miyashiro H, Shimoi K, Okada H, Kanzaki H. Ten-year outcome of semen cryopreservation for patients with malignant disease and preservation system at Kansai Medical University. Hinyokika Kiyo. 2011;57:367–71.
Wallace WH, Thomson AB. Preservation of fertility in children treated for cancer. Arch Dis Child. 2003;88:493–6.
Schrader M, Müller M, Sofikitis N, Straub B, Krause H, Miller K. “Onco-tese”: testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines? Urology. 2003;61:421–5.
Furuhashi K, Ishikawa T, Hashimoto H, Yamada S, Ogata S, Mizusawa Y, Matsumoto Y, Okamoto E, Kokeguchi S, Shiotani M. Onco-testicular sperm extraction: testicular sperm extraction in azoospermic and very severely oligozoospermic cancer patients. Andrologia. 2013;45:107–10.
Descombe L, Chauleur C, Gentil-Perret A, Aknin-Seifer I, Tostain J, Lévy R. Testicular sperm extraction in a single cancerous testicle in patients with azoospermia: a case report. Fertil Steril. 2008;90:443.e1–4.
Carmignani L, Gadda F, Gazzano G, Ragni G, Paffoni A, Rocco F, Colpi GM. Testicular sperm extraction in cancerous testicle in patients with azoospermia: a case report. Hum Reprod. 2007;22:1068–72.
Goossens E, Van Saen D, Tournaye H. Spermatogonial stem cell preservation and transplantation: from research to clinic. Hum Reprod. 2013;28:897–907.
Sato T, Katagiri K, Gohbara A, Inoue K, Ogonuki N, Ogura A, Kubota Y, Ogawa T. In vitro production of functional sperm in cultured neonatal mouse testes. Nature. 2011;471:504–7.
Conflict of interest
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chiba, K., Fujisawa, M. Fertility preservation in men with cancer. Reprod Med Biol 13, 177–184 (2014). https://doi.org/10.1007/s12522-014-0180-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12522-014-0180-6